Zurcher Kantonalbank Zurich Cantonalbank Has $477,000 Position in Addus HomeCare Corporation (NASDAQ:ADUS)

Key Points

• Zurcher Kantonalbank Zurich Cantonalbank reduced its position in Addus HomeCare Corporation by 42.2% during the first quarter, leaving them with 4,823 shares valued at $477,000.
• Addus HomeCare's stock has a market cap of $2.01 billion and reported a 21.8% increase in quarterly revenue year-over-year.
• Analysts have a consensus rating of "Buy" for Addus HomeCare, with target prices ranging from $133.00 to $150.00 per share.

Zurcher Kantonalbank Zurich Cantonalbank lowered its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 42.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,823 shares of the company's stock after selling 3,520 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Addus HomeCare were worth $477,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in ADUS. Alliancebernstein L.P. raised its position in shares of Addus HomeCare by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock valued at $2,465,000 after purchasing an additional 91 shares during the period. Natixis increased its position in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares during the period. Heritage Family Offices LLP increased its position in Addus HomeCare by 6.3% during the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after acquiring an additional 143 shares during the period. Hohimer Wealth Management LLC increased its position in Addus HomeCare by 6.3% during the first quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after acquiring an additional 152 shares during the period. Finally, Stifel Financial Corp increased its position in Addus HomeCare by 1.2% during the fourth quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after acquiring an additional 153 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $109.10 on Friday. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market cap of $2.01 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 1.72 and a beta of 0.80. The company has a fifty day moving average price of $111.77 and a 200-day moving average price of $108.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm's quarterly revenue was up 21.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.35 EPS. As a group, equities research analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ADUS shares. TD Cowen increased their price objective on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a research note on Wednesday. Macquarie restated an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Wednesday, July 16th. Finally, Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Addus HomeCare currently has a consensus rating of "Buy" and a consensus target price of $142.86.

Insider Buying and Selling

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the company's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president directly owned 7,796 shares of the company's stock, valued at $896,540. This represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is currently owned by company insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.